Angiopoietin
Agonists: Angiopoietin 1
Angiopoietin 4
Antagonists: Angiopoietin 2
Kinase inhibitors:
Rebastinib
Antibodies: Evinacumab (against angiopoietin 3)
Nesvacumab (against angiopoietin 2)
CNTF EGF (ErbB)
EGF(ErbB1/HER1)
Agonists : Amphiregulin
Betacellulin
EGF (urogastrone)
Epigen
Epiregulin
Heparin-binding EGF-like growth factor (HB-EGF)
Murodermin
Nepidermin
Transforming growth factor alpha (TGFα)
Kinase inhibitors: Afatinib
Brigatinib
Canertinib
Dacomitinib
Erlotinib
Gefitinib
Grandinin
Icotinib
Lapatinib
Neratinib
Osimertinib
Vandetanib
ErbB2/HER2
Antibodies: Ertumaxomab
Pertuzumab
Trastuzumab
Trastuzumab deruxtecan
Trastuzumab emtansine
Kinase inhibitors: Afatinib
Lapatinib
Mubritinib
Neratinib
Tucatinib
ErbB3/HER3
Antibodies: Duligotumab
Patritumab
Seribantumab
ErbB4/HER4
FGF
FGFR1 FGFR2
Agonists:
FGF (1 , 2 (bFGF) , 3 , 4 , 5 , 6 , 7 (KGF ), 8 , 9 , 10 (KGF2) , 17 , 18 , 22 )
Palifermin
Selpercatinib
Sprifermin
Trafermin
Kinase inhibitors: Infigratinib
FGFR3
Antibodies: Burosumab (against FGF23)
FGFR4 Unsorted
HGF (c-Met)
Agonists :
Hepatocyte growth factor
Potentiators: Dihexa (PNB-0408)
IGF
IGF-1
Agonists : des(1-3)IGF-1
Insulin-like growth factor-1 (somatomedin C)
IGF-1 LR3
Insulin-like growth factor-2 (somatomedin A)
Insulin
Mecasermin
Mecasermin rinfabate
Kinase inhibitors:
Linsitinib
IGF-2
Agonists : Insulin-like growth factor-2 (somatomedin A)
Antibodies: Dusigitumab
(against IGF-1 and IGF-2)
Others
Cleavage products/derivatives with unknown target:
Trofinetide
LNGF (p75NTR )
Antagonists:
Dexamethasone
Testosterone
PDGF
Agonists: Becaplermin
Platelet-derived growth factor (A , B , C , D )
Kinase inhibitors:
Avapritinib
Axitinib
Crenolanib
Imatinib
Lenvatinib
Masitinib
Motesanib
Nintedanib
Pazopanib
Radotinib
Quizartinib
Ripretinib
Sunitinib
Sorafenib
Toceranib
RET (GFL)
SCF (c-Kit)
Kinase inhibitors:
Axitinib
Dasatinib
Imatinib
Masitinib
Nilotinib
Pazopanib
Quizartinib
Sorafenib
Sunitinib
Toceranib
TGFβ Trk
TrkA
Antagonists:
Dexamethasone
FX007
Testosterone
Negative allosteric modulators:
Kinase inhibitors:
Entrectinib
K252a
Larotrectinib
Lestaurtinib
Rebastinib
)
TrkB
Kinase inhibitors:
Entrectinib
K252a
Larotrectinib
Lestaurtinib
TrkC
Kinase inhibitors:
Entrectinib
K252a
Larotrectinib
Lestaurtinib
VEGF
Agonists: Placental growth factor (PGF)
Ripretinib
VEGF (A , B , C , D (FIGF) )
Antibodies: Alacizumab pegol
Bevacizumab
Icrucumab
Ramucirumab
Ranibizumab
Decoy receptors: Aflibercept
Others
Additional growth factors: Adrenomedullin
Colony-stimulating factors (see here instead)
Connective tissue growth factor (CTGF)
Ephrins (A1 , A2 , A3 , A4 , A5 , B1 , B2 , B3 )
Erythropoietin (see here instead)
Glucose-6-phosphate isomerase (GPI; PGI, PHI, AMF)
Glia maturation factor (GMF)
Hepatoma-derived growth factor (HDGF)
Interleukins /T-cell growth factors (see here instead)
Leukemia inhibitory factor (LIF)
Macrophage-stimulating protein (MSP; HLP, HGFLP)
Midkine (NEGF2)
Migration-stimulating factor (MSF; PRG4)
Oncomodulin
Pituitary adenylate cyclase-activating peptide (PACAP)
Pleiotrophin
Renalase
Thrombopoietin (see here instead)
Wnt signaling proteins
Additional growth factor receptor modulators: Cerebrolysin (neurotrophin mixture)